The post David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century appeared on BitcoinEthereumNewsThe post David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century appeared on BitcoinEthereumNews

David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century

For feedback or concerns regarding this content, please contact us at [email protected]


Age reversal research could redefine human health, with trials soon to begin on reversing blindness.

Key takeaways

  • Aging is not an inevitable process and can potentially be reversed.
  • People may live into the twenty-second century with the right practices.
  • Reversing aging could lead to cures for diseases like Alzheimer’s, cancer, and heart disease.
  • Understanding and reversing aging could have the biggest impact on human health in history.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • We can safely reset the age of cells by about 75%.
  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • Aging is a universal process that can potentially be reversed, changing our understanding of health.
  • Age reversal research could transform human history.
  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • Advances in longevity research suggest a transformative future for human life expectancy.
  • The potential benefits of aging research underscore its importance in the field of health.

Guest intro

David A. Sinclair, A.O., Ph.D. is a Professor of Genetics in the Department of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for Biology of Aging Research. He co-discovered a cause of aging in yeast and the role of Sir2 in epigenetic changes during his postdoctoral work at MIT. His lab demonstrated that aging can be reversed in animal models to cure blindness.

Why aging is not inevitable

  • — David Sinclair

  • Sinclair challenges the belief that aging is a natural and acceptable process.
  • — David Sinclair

  • Reversing aging could cure major diseases like Alzheimer’s and cancer.
  • — David Sinclair

  • Understanding aging could have the biggest impact on human health in history.
  • — David Sinclair

  • Aging is a universal process that can be potentially reversed, fundamentally changing health perspectives.
  • — David Sinclair

The potential for living into the twenty-second century

  • People may live into the twenty-second century with the right practices.
  • — David Sinclair

  • Advances in longevity research suggest a transformative future for human life expectancy.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • — David Sinclair

  • Age reversal research could transform human history.
  • — David Sinclair

  • The potential benefits of aging research underscore its importance in the field of health.

The role of gene therapy in age reversal

  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • — David Sinclair

  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • — David Sinclair

  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • — David Sinclair

  • Advances in gene therapy could lead to significant breakthroughs in age-related conditions.

Resetting cellular age

  • We can safely reset the age of cells by about 75%.
  • — David Sinclair

  • This process does not regress cells back to zero, which is beneficial.
  • — David Sinclair

  • Understanding cellular age resetting has potential applications in medicine.
  • This claim presents a significant advancement in cellular aging research.
  • Cellular age resetting is central to Sinclair’s research and its potential impact on health.

The information theory of aging

  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • — David Sinclair

  • This theory provides insight into the scientific foundation of Sinclair’s work.
  • Understanding this theory is crucial for grasping the potential to reverse aging.
  • The information theory of aging underpins Sinclair’s confidence in reversing aging.
  • This theory suggests a transformative approach to understanding biological aging.
  • The potential to reverse aging is grounded in a solid scientific framework.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Age reversal research could redefine human health, with trials soon to begin on reversing blindness.

Key takeaways

  • Aging is not an inevitable process and can potentially be reversed.
  • People may live into the twenty-second century with the right practices.
  • Reversing aging could lead to cures for diseases like Alzheimer’s, cancer, and heart disease.
  • Understanding and reversing aging could have the biggest impact on human health in history.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • We can safely reset the age of cells by about 75%.
  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • Aging is a universal process that can potentially be reversed, changing our understanding of health.
  • Age reversal research could transform human history.
  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • Advances in longevity research suggest a transformative future for human life expectancy.
  • The potential benefits of aging research underscore its importance in the field of health.

Guest intro

David A. Sinclair, A.O., Ph.D. is a Professor of Genetics in the Department of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for Biology of Aging Research. He co-discovered a cause of aging in yeast and the role of Sir2 in epigenetic changes during his postdoctoral work at MIT. His lab demonstrated that aging can be reversed in animal models to cure blindness.

Why aging is not inevitable

  • — David Sinclair

  • Sinclair challenges the belief that aging is a natural and acceptable process.
  • — David Sinclair

  • Reversing aging could cure major diseases like Alzheimer’s and cancer.
  • — David Sinclair

  • Understanding aging could have the biggest impact on human health in history.
  • — David Sinclair

  • Aging is a universal process that can be potentially reversed, fundamentally changing health perspectives.
  • — David Sinclair

The potential for living into the twenty-second century

  • People may live into the twenty-second century with the right practices.
  • — David Sinclair

  • Advances in longevity research suggest a transformative future for human life expectancy.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • — David Sinclair

  • Age reversal research could transform human history.
  • — David Sinclair

  • The potential benefits of aging research underscore its importance in the field of health.

The role of gene therapy in age reversal

  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • — David Sinclair

  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • — David Sinclair

  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • — David Sinclair

  • Advances in gene therapy could lead to significant breakthroughs in age-related conditions.

Resetting cellular age

  • We can safely reset the age of cells by about 75%.
  • — David Sinclair

  • This process does not regress cells back to zero, which is beneficial.
  • — David Sinclair

  • Understanding cellular age resetting has potential applications in medicine.
  • This claim presents a significant advancement in cellular aging research.
  • Cellular age resetting is central to Sinclair’s research and its potential impact on health.

The information theory of aging

  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • — David Sinclair

  • This theory provides insight into the scientific foundation of Sinclair’s work.
  • Understanding this theory is crucial for grasping the potential to reverse aging.
  • The information theory of aging underpins Sinclair’s confidence in reversing aging.
  • This theory suggests a transformative approach to understanding biological aging.
  • The potential to reverse aging is grounded in a solid scientific framework.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Loading more articles…

You’ve reached the end


Add us on Google

`;
}

function createMobileArticle(article) {
const displayDate = getDisplayDate(article);
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const authorHtml = article.isPressRelease ? ” : `
`;

return `


${captionHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${createSocialShare()}

${authorHtml}
${displayDate}

${article.content}

${article.isPressRelease ? ” : article.isSponsored ? `

Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function createDesktopArticle(article, sidebarAdHtml) {
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const displayDate = getDisplayDate(article);
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const categoriesHtml = article.categories.map((cat, i) => {
const separator = i < article.categories.length – 1 ? ‘|‘ : ”;
return `${cat}${separator}`;
}).join(”);
const desktopAuthorHtml = article.isPressRelease ? ” : `
`;

return `

${categoriesHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${desktopAuthorHtml}
${displayDate}
${createSocialShare()}

${captionHtml}

${article.content}
${article.isPressRelease ? ” : article.isSponsored ? `
Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function loadMoreArticles() {
if (isLoading || !hasMore) return;

isLoading = true;
loadingText.classList.remove(‘hidden’);

// Build form data for AJAX request
const formData = new FormData();
formData.append(‘action’, ‘cb_lovable_load_more’);
formData.append(‘current_post_id’, lastLoadedPostId);
formData.append(‘primary_cat_id’, primaryCatId);
formData.append(‘before_date’, lastLoadedDate);
formData.append(‘loaded_ids’, loadedPostIds.join(‘,’));

fetch(ajaxUrl, {
method: ‘POST’,
body: formData
})
.then(response => response.json())
.then(data => {
isLoading = false;
loadingText.classList.add(‘hidden’);

if (data.success && data.has_more && data.article) {
const article = data.article;
const sidebarAdHtml = data.sidebar_ad_html || ”;

// Check for duplicates
if (loadedPostIds.includes(article.id)) {
console.log(‘Duplicate article detected, skipping:’, article.id);
// Update pagination vars and try again
lastLoadedDate = article.publishDate;
loadMoreArticles();
return;
}

// Add to mobile container
mobileContainer.insertAdjacentHTML(‘beforeend’, createMobileArticle(article));

// Add to desktop container with fresh ad HTML
desktopContainer.insertAdjacentHTML(‘beforeend’, createDesktopArticle(article, sidebarAdHtml));

// Update tracking variables
loadedPostIds.push(article.id);
lastLoadedPostId = article.id;
lastLoadedDate = article.publishDate;

// Execute any inline scripts in the new content (for ads)
const newArticle = desktopContainer.querySelector(`article[data-article-id=”${article.id}”]`);
if (newArticle) {
const scripts = newArticle.querySelectorAll(‘script’);
scripts.forEach(script => {
const newScript = document.createElement(‘script’);
if (script.src) {
newScript.src = script.src;
} else {
newScript.textContent = script.textContent;
}
document.body.appendChild(newScript);
});
}

// Trigger Ad Inserter if available
if (typeof ai_check_and_insert_block === ‘function’) {
ai_check_and_insert_block();
}

// Trigger Google Publisher Tag refresh if available
if (typeof googletag !== ‘undefined’ && googletag.pubads) {
googletag.cmd.push(function() {
googletag.pubads().refresh();
});
}

} else if (data.success && !data.has_more) {
hasMore = false;
endText.classList.remove(‘hidden’);
} else if (!data.success) {
console.error(‘AJAX error:’, data.error);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
}
})
.catch(error => {
console.error(‘Fetch error:’, error);
isLoading = false;
loadingText.classList.add(‘hidden’);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
});
}

// Set up IntersectionObserver
const observer = new IntersectionObserver(function(entries) {
if (entries[0].isIntersecting) {
loadMoreArticles();
}
}, { threshold: 0.1 });

observer.observe(loadingTrigger);
})();

© Decentral Media and Crypto Briefing® 2026.

Source: https://cryptobriefing.com/david-sinclair-aging-can-be-reversed-gene-therapy-is-key-to-rejuvenation-and-we-may-live-into-the-twenty-second-century-the-diary-of-a-ceo/

Market Opportunity
SOON Logo
SOON Price(SOON)
$0.1215
$0.1215$0.1215
-3.41%
USD
SOON (SOON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

The Samourai Wallet domain, which was previously seized by the FBI, is now under the control of scammers who are using it to steal Bitcoin.

The Samourai Wallet domain, which was previously seized by the FBI, is now under the control of scammers who are using it to steal Bitcoin.

PANews reported on March 24th that, according to Cryptopolitan, the domain of Samourai Wallet, a Bitcoin wallet once known for its privacy features, has been seized
Share
PANews2026/03/24 09:03
How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings

How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings

The post How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings appeared on BitcoinEthereumNews.com. contributor Posted: September 17, 2025 As digital assets continue to reshape global finance, cloud mining has become one of the most effective ways for investors to generate stable passive income. Addressing the growing demand for simplicity, security, and profitability, IeByte has officially upgraded its fully automated cloud mining platform, empowering both beginners and experienced investors to earn Bitcoin, Dogecoin, and other mainstream cryptocurrencies without the need for hardware or technical expertise. Why cloud mining in 2025? Traditional crypto mining requires expensive hardware, high electricity costs, and constant maintenance. In 2025, with blockchain networks becoming more competitive, these barriers have grown even higher. Cloud mining solves this by allowing users to lease professional mining power remotely, eliminating the upfront costs and complexity. IeByte stands at the forefront of this transformation, offering investors a transparent and seamless path to daily earnings. IeByte’s upgraded auto-cloud mining platform With its latest upgrade, IeByte introduces: Full Automation: Mining contracts can be activated in just one click, with all processes handled by IeByte’s servers. Enhanced Security: Bank-grade encryption, cold wallets, and real-time monitoring protect every transaction. Scalable Options: From starter packages to high-level investment contracts, investors can choose the plan that matches their goals. Global Reach: Already trusted by users in over 100 countries. Mining contracts for 2025 IeByte offers a wide range of contracts tailored for every investor level. From entry-level plans with daily returns to premium high-yield packages, the platform ensures maximum accessibility. Contract Type Duration Price Daily Reward Total Earnings (Principal + Profit) Starter Contract 1 Day $200 $6 $200 + $6 + $10 bonus Bronze Basic Contract 2 Days $500 $13.5 $500 + $27 Bronze Basic Contract 3 Days $1,200 $36 $1,200 + $108 Silver Advanced Contract 1 Day $5,000 $175 $5,000 + $175 Silver Advanced Contract 2 Days $8,000 $320 $8,000 + $640 Silver…
Share
BitcoinEthereumNews2025/09/17 23:48
Snorter Bot Token Nears $4M in ICO as Major Ecosystem Updates Roll Out

Snorter Bot Token Nears $4M in ICO as Major Ecosystem Updates Roll Out

As Telegram trading bot Snorter Bot Token (SNORT) nears $4 million in presale funding, the project has also rolled out major ecosystem updates that strengthen its position as a serious competitor to existing Telegram bots.Snorter is Solana-native by design, which gives it faster speeds and lower transaction costs than Ethereum-based rivals that remain weighed down […] The post Snorter Bot Token Nears $4M in ICO as Major Ecosystem Updates Roll Out appeared first on Cryptonews.
Share
Coinstats2025/09/19 02:34